HighPoint Advisor Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,086
Closed -$503K 965
2025
Q4
$503K Buy
2,086
+15
+0.7% +$3.84K 0.01% 667
2025
Q3
$567K Sell
2,071
-41
-2% -$11.2K 0.03% 365
2025
Q2
$545K Buy
2,112
+17
+0.8% +$4.05K 0.03% 356
2025
Q1
$498K Sell
2,095
-475
-18% -$111K 0.03% 359
2024
Q4
$610K Buy
2,570
+64
+3% +$15.4K 0.03% 332
2024
Q3
$612K Buy
2,506
+64
+3% +$14.3K 0.04% 322
2024
Q2
$508K Buy
2,442
+11
+0.5% +$2.23K 0.03% 346
2024
Q1
$530K Buy
2,431
+19
+0.8% +$3.48K 0.04% 338
2023
Q4
$466K Buy
+2,412
New +$371K 0.03% 367
2022
Q2
$419K Buy
+1,928
New +$410K 0.05% 321
2021
Q3
$506K Buy
1,918
+73
+4% +$20K 0.05% 305
2021
Q2
$455K Buy
1,845
+355
+24% +$74.6K 0.05% 322
2021
Q1
$297K Buy
1,490
+160
+12% +$32.1K 0.03% 372
2020
Q4
$266K Buy
1,330
+50
+4% +$9.97K 0.03% 376
2020
Q3
$272K Buy
1,280
+98
+8% +$18.1K 0.05% 292
2020
Q2
$226K Sell
1,182
-57
-5% -$9.33K 0.05% 294
2020
Q1
$199K Buy
+1,239
New +$197K 0.05% 301
2019
Q4
Sell
-1,167
Closed -$167K 455
2019
Q3
$167K Buy
1,167
+4
+0.3% +$524 0.04% 346
2019
Q2
$143K Buy
+1,163
New +$129K 0.03% 368

Other funds holding RMD

HighPoint Advisor Group's RMD Position: Q1 2026 in Review

HighPoint Advisor Group sold out of ResMed (RMD) in Q1 2026, closing a stake of 2,086 shares — an estimated $503K sold.

HighPoint Advisor Group first reported a position in RMD in Q2 2019 and held it in 19 quarters. The position peaked at $612K in Q3 2024. 941 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • HighPoint Advisor Group reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • HighPoint Advisor Group sold 2,086 ResMed shares in Q1 2026, an estimated $503K.
  • HighPoint Advisor Group first reported a position in ResMed in Q2 2019 and held it in 19 quarters.
  • HighPoint Advisor Group's ResMed position peaked at $612K in Q3 2024.
  • 941 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.